期刊文献+

精子相关抗原9在子宫平滑肌肉瘤中的表达及临床意义 被引量:3

Expression and clinical significance of sperm associated antigen 9 in the tissue of leiomyosarcoma
下载PDF
导出
摘要 目的:研究子宫平滑肌肉瘤,富于细胞性子宫平滑肌瘤及子宫平滑肌瘤组织中精子相关抗原9(SPAG9)的表达及临床意义。方法:应用免疫组织化学技术检测19例子宫平滑肌肉瘤,22例富于细胞性子宫平滑肌瘤及30例子宫平滑肌瘤组织中SPAG9蛋白的表达。结果:SPAG9在子宫平滑肌肉瘤及富于细胞性子宫平滑肌瘤中表达率均为100%,在子宫平滑肌瘤中的表达率为0。根据Formwitz评分比较:SPAG9蛋白在子宫平滑肌肉瘤组织中的表达高于富于细胞性子宫平滑肌瘤和子宫平滑肌瘤中的表达,差异有统计学意义(P<0.05);子宫平滑肌肉瘤组织的表达中,不同核分裂数组织SPAG9蛋白的表达差异无统计学意义(P>0.05),细胞异型性不同的组织SPAG9蛋白的表达差异有统计学意义(P<0.05)。结论:SPAG9蛋白的异常表达与子宫平滑肌肉瘤的发生及预后相关,有望成为子宫平滑肌肉瘤与富于细胞性子宫平滑肌瘤鉴别诊断的生物学标记。 Objective:To investigate the expression of sperm associated antigen9(SPAG9)in the tissue of leiomyosarcoma,cellular leiomyoma and uterine leiomyoma and its clinical significance.Methods:Immunohistochemistry staining were used to detect the expression of SPAG9 on the protein level in the tissue obtained from 19 patients with leiomyosarcoma,22 patients with cellular leiomyoma and 30 patients with uterine leiomyoma.Results:In the tissue of leiomyosarcoma,SPAG9 expression rate was 100%,In the cellular leiomyoma the expression rate was 100%,and the expression rate in leiomyoma tissue was 0.The Formwitz score of leiomyosarcoma tissue was higher than cellular leiomyoma and uterine leiomyoma,the difference was statistically significant(P0.05).In the expression of SPAG9 in leiomyosarcoma,different number of nuclear division tissue have different SPAG9 protein expression,the difference was not statistically significant(P0.05).Different cellular atypia tissue have different SPAG9 protein expression,and the difference is statistically significant(P0.05).Conclusion:The abnormal expression of SPAG9 protein in leiomyosarcoma might be related with the occurrence and prognosis of leiomyosarcoma.SPAG9 has the possibility to be the biological marker for differential diagnosis of leiomyosarcoma and cellular leiomyoma.
出处 《现代妇产科进展》 CSCD 2012年第5期357-360,共4页 Progress in Obstetrics and Gynecology
基金 山东省自然科学基金(No:ZR2010HM005)
关键词 精子相关抗原9 子宫平滑肌肉瘤 富于细胞性子宫平滑肌瘤 鉴别诊断 Sperm related antigen 9 Leiomyosarcoma Cellular leiomyoma Differential diagnosis
  • 相关文献

参考文献3

  • 1Wei CL, Wu Q, Vega VB, et al. A global map of P53 transcription factor binding sites in the human Genome [ J]. Cell ,2006,124:207-219.
  • 2Kanojia D, Garg M, Gnpta S, et al. Sperm-associated anti- gen 9 is a novel biomarker for eolorectal cancer and is in- volved in tumor growth and tumorigenicity [ J ]. Am J pathol,2011,178 ( 3 ) : 1009-1020.
  • 3Manoj G, Deepika K,Salhan S, et al. Sperm-associated an-tigen 9 is a biomaker for early cervical carcinoma [ J]. Cancer,2009,115 ( 12 ) :2671-2683.

同被引文献28

  • 1杨萌,姜玉新.超声在子宫肉瘤诊断中的应用价值[J].中国医学影像技术,2006,22(2):307-309. 被引量:11
  • 2沈铿,崔恒,丰有吉.常用妇科恶性肿瘤诊治指南[M].北京:人民出版社,2004:73.
  • 3Tasaki A, Asatani MO, Umezu H, et al. Differential diag- nosis of uterine smooth muscle tumors using diffusion-weigh- ted imaging: correlations with the apparent diffusion coeffi- cient and cell density [J]. Abdom Imaging, 2014.
  • 4Juang CM, Yen MS, Homg HC, et al. Potential role of preoperative serum CA125 for the differential diagnosis be- tween uterine leiomyoma and uterine leiomyosareoma [J ] . Eur J Gynaecol Oncol, 2006, 27 (4) : 370-374.
  • 5Matsuda M, Ichimura T, Kasai M, et al. Preoperative di- agnosis of usual leiomyoma, atypical leiomyoma, and leiomy- osarcoma [J]. Sarcoma, 2014: 498682.
  • 6Kawamura N, Ichimura T, Ito F, et al. Transcervical nee- dle biopsy for the differential diagnosis between uterine sarco- maandleiomyoma [J] - Cancer, 2002, 94 (6): 1713- 1720.
  • 7Gagua IR. Incidence of ovarian metastases in uterine leiomyo- sarcoma and optimal surgery [ J ] . Gynecol Oncol, 2014, 133 (1): 126.
  • 8Mancari R, Signorelli M, Gadducci A, et al. Adjuvant chemotherapy in stage I-II uterine leiomyosarcoma: a muhi- centric retrospective study of 140 patients [J ] . Gynecol Oncol, 2014, 133 (3): 531-536.
  • 9Ricci S, Giuntoli RL 2nd, Eisenhauer E, et al. Does adju- vant chemotherapy improve survival for women with early- stage uterine leiomyosarcoma? [J] . Gynecol Oncol, 2013, 131 (3) : 629-633.
  • 10Lin J, Beriwal S, Olawaiye A, et al. Prognostic indicators, including role of surgery, radiotherapy and chemotherapy in non-metastatic uterine leiomyosarcoma: A series of 2379 pa- tients [J]. Gynecol Oncol, 2013, 13l (1): 283.

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部